If you’ve spent any time researching peptide therapy for injury recovery or gut health, you’ve likely come across BPC-157. It’s one of the most widely studied peptides in regenerative and functional medicine, with a research history that now spans more than three decades. Here’s what the science actually shows.
What Is BPC-157?
BPC stands for Body Protection Compound. BPC-157 is a synthetic peptide — a short chain of amino acids, specifically 15 amino acids long (a “pentadecapeptide”) — modeled on a naturally occurring protective protein found in human gastric juice.¹ In the body, this parent protein’s primary role is to protect the stomach and intestinal lining, support the healing of ulcers, and help regulate inflammation in the digestive tract.
Because of these protective properties, researchers have studied BPC-157 extensively over the past 30+ years, publishing findings on effects that extend well beyond the gut. Across a large body of preclinical research, it behaves as a signaling molecule that supports cellular repair processes throughout the body — one review describes it as capable of “organoprotection” that extends from the stomach to the liver, pancreas, heart, lungs, and nervous system.²
It’s important to note upfront that the overwhelming majority of this research — including the studies cited below — has been conducted in animal models (primarily rats and mice), with far more limited data in humans. That distinction matters, and we’ll come back to it.
How Does BPC-157 Work?
Preclinical research suggests BPC-157 works through several interconnected pathways. One well-documented mechanism is its interaction with the nitric oxide (NO) system, which helps maintain the health of blood vessel linings (the endothelium).¹,² This appears to support angiogenesis — the formation of new blood vessels — which in animal models increases blood flow to damaged tissue and helps deliver the oxygen and nutrients needed for repair.³
Research also points to rapid downstream signaling: studies have observed changes in gene expression (including genes tied to growth factor receptors, like VEGFR2, and cell survival pathways like AKT/eNOS) within minutes of tissue injury.² BPC-157 has also been shown in animal studies to help modulate the inflammatory response and reduce markers of oxidative stress, without appearing to interfere with normal collagen synthesis — an important distinction, since many anti-inflammatory approaches can slow tissue repair as a tradeoff.²
The Research on BPC-157’s Potential Benefits
Gut Health
This is where BPC-157 research began, and it remains the most extensively studied application. Animal studies have shown it counteracts gastric lesions caused by alcohol and NSAIDs, and can help heal pre-existing ulcers, complex fistulas, and surgical anastomoses.⁴ Notably, it was also investigated in early-phase human trials for ulcerative colitis under the name PL14736, one of the few areas where human data exists.⁴,⁵
Muscle, Tendon, and Ligament recovery
Several animal studies have examined BPC-157’s role in musculoskeletal healing. Research on tendon injury found it promoted tendon cell outgrowth, survival, and migration, supporting more organized repair.⁶ A broader review of BPC-157 in musculoskeletal and orthopedic contexts notes it has shown effects across muscle, tendon, ligament, and bone-junction healing in animal models — with the researchers pointing out an advantage over conventional growth factors (like VEGF or BMPs), which often require carrier systems or controlled-release delivery to be effective.⁷
Inflammation
Beyond localized injury, BPC-157 has been studied for systemic anti-inflammatory effects in animal models, including its ability to help normalize immune cell activity that had been suppressed by corticosteroids.²
Brain and Nervous System Effects
This is one of the newer and less-established areas of research. Preclinical studies have explored BPC-157 in the context of the gut-brain axis, including effects on enteric neuron survival and its ability to counteract certain neurotoxin-induced damage in animal models.²,⁸ Human clinical evidence for cognitive or neurological benefits is not yet available, so this remains an area to watch rather than a settled conclusion.
How Is BPC-157 Administered?
In the research literature, BPC-157 has been studied via several routes — systemic (intraperitoneal injection, subcutaneous injection, or orally through drinking water) and local application (such as a topical cream).⁷ Its stability in gastric acid is one of the features that originally distinguished it from other peptides, which is why oral formulations are of particular interest for gastrointestinal applications, while subcutaneous administration is more commonly used when the goal is a systemic effect on muscle, tendon, or joint tissue.
A Note on Where the Science Stands
BPC-157 is not an FDA-approved drug, and its regulatory status in the U.S. has been actively evolving. As of 2026, it is no longer flagged under the FDA’s prior safety-concern category, but not yet formally cleared either.⁹ For perspective, about 21% of all prescriptions written in the U.S. are non-FDA approved reasons, also known as off-label usage10. Off-label usage rates can be much higher (>50%) for certain specialties11.
BPC-157 and Functional Medicine
Functional medicine looks at peptides like BPC-157 as one tool among many for supporting the body’s own repair processes — not as a standalone fix. At Arizona Wellness Medicine, we take a whole-person approach: identifying the root cause of your symptoms rather than just managing them. When a peptide like BPC-157 is appropriate for a patient’s situation, we’ve found it tends to work best as part of a broader plan that includes an anti-inflammatory diet, regular exercise, stress management, and quality sleep — the foundational inputs your body needs to actually use the repair signals a peptide provides.
Ready to Start Your Healing Journey?
If you’re dealing with a stubborn injury, gut symptoms, or chronic inflammation and want to know whether peptide therapy fits into your care, Arizona Wellness Medicine works one-on-one with you to build a personalized treatment plan aimed at lasting relief. Visit azwellmed.com for more information or call our office at 602-892-4727 to get started!
References
1. Sikirić, P., et al. “Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.” Frontiers in Pharmacology, 2021. frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.627533/full
2. Sikirić, P., et al. “Stable Gastric Pentadecapeptide BPC 157, Robert’s Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response.” Gut and Liver, 2020. gutnliver.org/journal/view.html?doi=10.5009/gnl18490
3. “From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.” PubMed. pubmed.ncbi.nlm.nih.gov/41898733/
4. “Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157.” PubMed. pubmed.ncbi.nlm.nih.gov/22300085/
5. “Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease… heals ileoileal anastomosis in the rat.” PubMed. pubmed.ncbi.nlm.nih.gov/17713731/
6. Chang, C.H., et al. “The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration.” Journal of Applied Physiology, 2011. journals.physiology.org/doi/full/10.1152/japplphysiol.00945.2010
7. “Tendon, Ligament, and Muscle Injury… Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157 — A Review.” Pharmaceuticals (MDPI), 2026. mdpi.com/1424-8247/19/2/309
8. “BPC-157 and the Gut-Brain Axis: Emerging Links Between Cytoprotection and Neuroregeneration.” Annales Academiae Medicae Silesiensis. annales.sum.edu.pl
9. “BPC-157 in 2026: Why Regulatory Limbo Is Not the Same as a Green Light.” Holt Law. djholtlaw.com/regulatory-alert-the-legal-status-of-bpc-157-in-compounding-and-clinical-practice/
10. Regulating Off-Label Drug Use — Rethinking the Role of the FDA. The New England Journal of Medicine. 2008. Stafford RS.
11. Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research +. Pharmacoepidemiology and Drug Safety. 2023. Gazarian M, Horton DB, Carleton B, et al.
This content is for educational purposes and reflects the current state of published research. It is not intended as medical advice or as a claim that BPC-157 diagnoses, treats, cures, or prevents any disease. Individual treatment plans should be discussed with a licensed provider.
